Featured Topics
Q3 2025 Teaser
November 12, 2025
Q3 2025 Results
Calendar

October 16, 2025

Quiet Period (October 16 - November 12)

November 12, 2025

Press Releases
Share Price / Index
October 30, 2025
PCB litigation: Washington Supreme Court ruling in Erickson
October 24, 2025
Not intended for U.S. and UK Media
Bayer’s Lynkuet™ (elinzanetant) approved in the U.S. for treatment of moderate to severe vasomotor symptoms due to menopause
September 22, 2025
Not intended for US and UK Media
Bayer first company to advance cell therapy as well as gene therapy against Parkinson’s disease

Our Products

Our broad product portfolio includes many world-famous brands that have shaped our Bayer brand. With our products, we are helping to find solutions to some of the greatest challenges of our time. So that health and nutrition can be made available to everyone.